semaglutide and bone density Recent studies suggest a potential link between GLP-1 drugs like Ozempic a modest increased risk of loss, osteoporosis, or bone-related injuries, particularly with rapid weight loss. While not typically " GLP-1s and bone loss!

Schedule a consultation with us for a comprehensive diagnosis and personalised treatment plan

Available in both injection and oral formats, this treatment mimics the GLP-1 hormone, effectively curbing appetite and supporting sustainable weight loss

Your comment will appear after moderation

10.1002/vms3.473 30

Variants in GLP1R (the GLP-1 receptor semaglutide targets), FTO (fat-mass and obesity-associated), MC4R (satiety and energy balance), and TCF7L2 (glucose homeostasis and GLP-1 secretion) map the terrain a semaglutide prescription enters

Diabetic ketoacidosis has been reported in insulin-dependent patients who began treatment with a GLP-1 receptor agonist and therefore had their insulin discontinued or their dose rapidly reduced